World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
105
Citations
42121
World Ranking
6753
National Ranking
3564

Overview

Madhu Mazumdar is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily centers on medicine, with a significant focus on public health, environmental and occupational health, economics and econometrics, oncology, surgery, and general health professions.

Their work covers a variety of topics including frailty in older adults, intensive care unit cognitive disorders, epilepsy research and treatment, COVID-19 clinical research studies, telemedicine and telehealth implementation, health systems, economic evaluations, quality of life, and economic and financial impacts of cancer.

Recent notable publications by Mazumdar include:

  • An inflammatory cytokine signature predicts COVID-19 severity and survival (2020, Nature Medicine)
  • Using Machine Learning to Predict ICU Transfer in Hospitalized COVID-19 Patients (2020, Journal of Clinical Medicine)
  • An inflammatory cytokine signature helps predict COVID-19 severity and death (2020, bioRxiv (Cold Spring Harbor Laboratory))
  • MEWS++: Enhancing the Prediction of Clinical Deterioration in Admitted Patients through a Machine Learning Model (2020, Journal of Clinical Medicine)
  • Development and validation of a machine learning-based prediction model for near-term in-hospital mortality among patients with COVID-19 (2020, BMJ Supportive & Palliative Care)

Mazumdar frequently collaborates with other researchers, including Lihua Li, Parul Agarwal, Arash Kia, Bian Liu, and Cardinale B. Smith. These coauthors contribute to the breadth and multidisciplinary nature of the research work.

Their work has appeared in several prominent publication venues, with multiple publications in the Journal of Clinical Oncology, Neurology, JCO Oncology Practice, bioRxiv (Cold Spring Harbor Laboratory), and the Journal of Pain and Symptom Management.

Best Publications

  • An inflammatory cytokine signature predicts COVID-19 severity and survival.

    Diane Marie Del Valle;Seunghee Kim-Schulze;Hsin-Hui Huang;Noam D. Beckmann

  • Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma

    Robert J. Motzer;Madhu Mazumdar;Jennifer Bacik;William Berg

  • Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma

    Robert J. Motzer;Jennifer Bacik;Barbara A. Murphy;Paul Russo

  • DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia

    Maria E. Figueroa;Sanne Lugthart;Yushan Li;Claudia Erpelinck-Verschueren

  • Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell Carcinoma

    Robert J. Motzer;Jennifer Bacik;Lawrence H. Schwartz;Victor Reuter

  • Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy

    Dean F. Bajorin;Paul M. Dodd;Madhu Mazumdar;Melissa Fazzari

  • Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

    Steven M. Larson;Yusuf Erdi;Timothy Akhurst;Madhu Mazumdar

  • Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma

    Abby B. Siegel;Emil I. Cohen;Allyson Ocean;Deborah Lehrer

  • Treatment Outcome and Survival Associated With Metastatic Renal Cell Carcinoma of Non–Clear-Cell Histology

    Robert J. Motzer;Jennifer Bacik;Tania Mariani;Paul Russo

  • Perioperative comparative effectiveness of anesthetic technique in orthopedic patients.

    Stavros G. Memtsoudis;Xuming Sun;Ya Lin Chiu;Ottokar Stundner

  • Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety.

    Jashvant Poeran;Rehana Rasul;Suzuko Suzuki;Thomas Danninger

  • Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments.

    Madhu Mazumdar;Jill R. Glassman

  • Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.

    Jose G. Guillem;David B. Chessin;Alfred M. Cohen;Jinru Shia

  • Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA.

    Stefan Worgall;Dolan Sondhi;Neil R. Hackett;Barry Kosofsky

  • Postoperative Nomogram for Disease-Specific Survival After an R0 Resection for Gastric Carcinoma

    Michael W. Kattan;Martin S. Karpeh;Madhu Mazumdar;Murray F. Brennan

  • Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors.

    Robert J. Motzer;Alison Amsterdam;Alison Amsterdam;Victor Prieto;Victor Prieto;Joel Sheinfeld;Joel Sheinfeld

  • Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer.

    Wm Kevin Kelly;Howard I. Scher;Madhu Mazumdar;Vaia Vlamis

  • Endoscopic pituitary surgery: a systematic review and meta-analysis.

    Abtin Tabaee;Vijay K Anand;Yolanda Barrón;David H Hiltzik

  • Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

    D F Bajorin;M F Sarosdy;D G Pfister;M Mazumdar

  • Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma.

    J A McCaffrey;S Hilton;M Mazumdar;S Sadan

Frequent Co-Authors

Robert J. Motzer
Robert J. Motzer Memorial Sloan Kettering Cancer Center
Paul J. Christos
Paul J. Christos Cornell University
Dean F. Bajorin
Dean F. Bajorin Memorial Sloan Kettering Cancer Center
Jose G. Guillem
Jose G. Guillem University of North Carolina at Chapel Hill
Bruce D. Minsky
Bruce D. Minsky The University of Texas MD Anderson Cancer Center
David Reich
David Reich Harvard Medical School
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Leonard Saltz
Leonard Saltz Memorial Sloan Kettering Cancer Center
Paul Russo
Paul Russo Memorial Sloan Kettering Cancer Center
Jinru Shia
Jinru Shia Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring medical professionals in the USA have a variety of flexible online options for advancing their education and careers. For registered nurses seeking advanced credentials, the cheapest dnp programs online can offer an affordable pathway to a Doctor of Nursing Practice (DNP) degree, preparing graduates for leadership roles in clinical and academic settings.

Those who have a nursing background and wish to further their skills can consider the cheapest bsn programs to complete a Bachelor of Science in Nursing (BSN) online. This degree not only enhances clinical knowledge but also increases job opportunities and earning potential.

For students who do not have a nursing degree but are interested in entering the field, online direct entry msn programs for non-nurses provide a streamlined route into nursing with a Master's degree. Additionally, options like online bsn programs for non nurses make it easier for applicants from non-nursing backgrounds to start rewarding careers in healthcare.

Best Scientists Citing Madhu Mazumdar

Trending Scientists

Recently Published Articles